<DOC>
	<DOCNO>NCT01835197</DOCNO>
	<brief_summary>This single- multiple-ascending dose study first evaluation PF-04965842 , Janus kinase1 ( JAK1 ) inhibitor , human . The goal ass safety , tolerability , pharmacokinetics pharmacodynamics healthy Western Japanese subject .</brief_summary>
	<brief_title>First-in-Human Study Evaluate Safety Tolerability Single Multiple Ascending Doses Janus Kinase-1 Inhibitor PF-04965842 Healthy Western Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive . Females must nonchild bear potential either least 1 year post menopausal ( FSH â‰¥40 IU/L ) , document hysterectomy ( without bilateral oophrectomy ) least 6 month prior study day Subjects willing defer receive prophylactic immunization ( e.g . influenza pneumococcal vaccine ) study . Absolute lymphocyte count must great equal low limit laboratory reference range . Subjects enrol Cohort 8 must four Japanese grandparent born Japan . Evidence history clinically significant hematological , renal , , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . History hepatitis positive test human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis B core antibody ( HBc Ab ) hepatitis C antibody ( HCV ) . Clinically significant abnormality chest Xray perform screen within 3 month screen date ; history tuberculosis active latent inadequately treated infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Randomized</keyword>
	<keyword>Double Blind</keyword>
	<keyword>Placebo-Controlled</keyword>
	<keyword>Single- &amp; Multiple Dose Escalation</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>PK</keyword>
	<keyword>PD</keyword>
	<keyword>Pf-04965842</keyword>
</DOC>